About Michael Silber

This author has not yet filled in any details.
So far Michael Silber has created 2722 blog entries.

Tennessee

According to the Department of Commerce and Insurance (TDCI) Rule 0780-01-95-.10(1)(b) and 0780-01-95-.10(2)(b), the deadline to submit an attestation of low-volume status and proof of actual prescription volume to your contracted PBMs is December 1, 2024. Volume status is based on your pharmacy's actual prescription volume from July 1, 2023, to June 30, 2024.  

Also in Tennessee, the Tennessee Pharmacy Association (TPA) is hosting a Pharmacy Technician Conference on November 16 from 9:00 am to 4:15 pm. Pharmacy technicians are invited to register at one of four locations across Tennessee to advance their careers, earn continuing education (CE) credit (including pharmacy law and patient safety) and develop valuable connections. 

Finally, register for the TPA and the Tennessee Pharmacists Consortium for Education's (TPCE's) training program, the PBM Playbook: Mastering MAC Appeals in TN. The three-session training program will be presented by Tyler Dougherty, an esteemed expert in PBM reform and compliance. The sessions are on November 6, November 20 and December 4. Please register in advance.  

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2024-10-31T13:15:53-04:00October 31, 2024|Tennessee|

Texas

The Health and Human Services Commission (HHSC) posted the biannual specialty drug list. 

Also in Texas, the Department of State Health Services (DSHS) combined the individual weekly influenza, respiratory syncytial virus (RSV) and COVID-19 surveillance reports into one report called the Texas Respiratory Virus Surveillance Report. A new Respiratory Illness Interactive Dashboard contains respiratory illness data including emergency department visits, hospitalizations and deaths associated with flu, RSV and COVID-19.  

Also in Texas, the DSHS offers an Immunization Toolkit with educational resources to help Texans understand the importance of protecting themselves and others with the flu vaccine.  

Also in Texas, the quarterly meeting of the Board of Pharmacy will be on November 5. The Board posted the agenda and will livestream the meeting.  

Finally in Texas, the Board of Pharmacy posted the October newsletter. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2024-10-31T13:15:20-04:00October 31, 2024|Texas|

Alaska

Gov. Mike Dunleavy (R) signed a bill into law that aims to ensure consumers have access to affordable prescriptions and level the playing field for pharmacies by regulating pharmacy benefit managers (PBMs) House Bill 226 – CHAPTER 61 SLA 24.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2024-10-24T14:08:54-04:00October 24, 2024|Alaska|

California

The Department of Health Care Services posted the following alerts, weekly notice, and monthly bulletin on the Medi-Cal Rx Web Portal:

Also in California, effective September 17, the opioid antagonist protocol was amended. The approved regulation text with changes has been posted by the Board of Pharmacy.

Also in California, starting January 1, 2025, personal license renewal applications will no longer be mailed and licenses that are eligible for renewal will be processed online.

Finally in California, the Department of Health Care Services posted the following:

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2024-10-24T14:08:23-04:00October 24, 2024|California|

Florida

The Agency for Health Care Administration will ensure reimbursement for all services provided in good faith to eligible Florida Medicaid recipients residing in the Florida counties affected by Hurricane Milton.

For providers within the State of Florida, along with out-of-state providers who are not enrolled with Florida Medicaid and who provided services to our displaced Florida residents, Florida Medicaid created a provisional provider enrollment process. Florida Medicaid has waived some initial requirements for providers to submit normally required information and documentation when applying for provisional enrollment. Details have been published in the “Florida Medicaid Health Care Alert” issued-on October 15, 2024.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2024-10-24T14:07:47-04:00October 24, 2024|Florida|

Indiana

The Health Coverage Programs (IHCP) issued a Medicaid provider bulletin BT2024166 reminding providers to use the new Gainwell Technologies addresses.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2024-10-24T14:06:45-04:00October 24, 2024|Indiana|

Kentucky

The Department for Medicaid Services (DMS) and MedImpact issued a bulletin to pharmacies promoting the administration of Human Papillomavirus (HPV) vaccines at pharmacies. Through December 1, 2024, pharmacies will receive a point-of-sale message when billing claims for Medicaid patients that DMS identified as HPV vaccine naive. Pharmacies may bill Medicaid for the product, the administration fee and counseling. NACDS serves on Medicaid’s Pharmacy Technical Advisory Committee (PTAC) that worked with DMS and the health plans to develop and advance the program. Fee-for-service and MedImpact contact information as well as the protocol have been provided to pharmacies.

Also in Kentucky, Medicaid and MedImpact issued bulletins related to MAC appeals and a reminder to pharmacies of their auto refill prohibition policy.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2024-10-24T14:06:00-04:00October 24, 2024|Kentucky|

Louisiana

The Department of Health (LDH) Bureau of Health Services Financing issued a notice informing Medicaid Pharmacy providers of the upcoming beneficiary third party liability (TPL) data migration that will begin on November 4, 2024. The TPL migration applies to pharmacy claims submitted to Gainwell for Fee for Service (FFS) and to Prime Therapeutics for MCOs (Aetna, AmeriHealth Caritas, Healthy Blue, Humana Healthy Horizons, Louisiana Healthcare Connections, and UnitedHealthcare).

Also in Louisiana, LDH issued an Informational Bulletin 24-37 updating the immunization fee schedule for 2024-2025.

Finally in Louisiana, on October 1, legislation signed into law by Gov. Jeff Landry (R) made Louisiana the first state to classify mifepristone and misoprostol, two abortion-inducing drugs, as controlled dangerous substances. While the drugs are still available with a prescription, they are now classified in the same category as some opioids.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2024-10-24T14:05:18-04:00October 24, 2024|Louisiana|
Go to Top